164 related articles for article (PubMed ID: 29491080)
1. Transitory Stoma at the Time of Complete Cytoreductive Surgery Affects Survival for Patients with Advanced-stage Ovarian Cancer.
Canlorbe G; Touboul C; Chargari C; Bentivegna E; Maulard A; Pautier P; Genestie C; Morice P; Gouy S
Anticancer Res; 2018 Mar; 38(3):1517-1523. PubMed ID: 29491080
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of three different managements after colorectal anastomosis in ovarian cancer: conservative management, diverting ileostomy, and ghost ileostomy.
Lago V; Sanchez-Migallón A; Flor B; Padilla-Iserte P; Matute L; García-Granero Á; Bustamante M; Domingo S
Int J Gynecol Cancer; 2019 Sep; 29(7):1170-1176. PubMed ID: 31296558
[TBL] [Abstract][Full Text] [Related]
3. Risk of definitive stoma after surgery for peritoneal malignancy in 958 patients: comparative study between complete cytoreductive surgery and maximal tumor debulking.
Riss S; Chandrakumaran K; Dayal S; Cecil TD; Mohamed F; Moran BJ
Eur J Surg Oncol; 2015 Mar; 41(3):392-5. PubMed ID: 25238953
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and outcomes after bowel surgery and ostomy formation at the time of debulking surgery for advanced-stage epithelial ovarian carcinoma.
Gockley AA; Fiascone S; Hicks Courant K; Pepin K; Del Carmen M; Clark RM; Goldberg J; Horowitz N; Berkowitz R; Worley M
Int J Gynecol Cancer; 2019 Mar; 29(3):585-592. PubMed ID: 30833444
[TBL] [Abstract][Full Text] [Related]
5. Rectosigmoidectomy and Douglas Peritonectomy in the Management of Serosal Implants in Advanced-Stage Ovarian Cancer Surgery: Survival and Surgical Outcomes.
Erkilinç S; Karataşli V; Demir B; Çakir İ; Can B; Karadeniz T; Gökçü M; Sanci M
Int J Gynecol Cancer; 2018 Nov; 28(9):1699-1705. PubMed ID: 30371561
[TBL] [Abstract][Full Text] [Related]
6. Indications and practice of diverting ileostomy after colorectal resection and anastomosis in ovarian cancer cytoreduction.
Lago V; Fotopoulou C; Chiantera V; Minig L; Gil-Moreno A; Cascales-Campos PA; Jurado M; Tejerizo A; Padilla-Iserte P; Malune ME; Di Donna MC; Marina T; Sanchez-Iglesias JL; Chiva L; Olloqui A; Matute L; García-Granero A; Cárdenas-Rebollo JM; Domingo S
Gynecol Oncol; 2020 Sep; 158(3):603-607. PubMed ID: 32571682
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and Predictive Value of the Peritoneal Cancer Index in Primary Advanced Epithelial Ovarian Cancer Patients After Complete Cytoreductive Surgery: Study of Tumor Bank Ovarian Cancer.
Gasimli K; Braicu EI; Richter R; Chekerov R; Sehouli J
Ann Surg Oncol; 2015 Aug; 22(8):2729-37. PubMed ID: 25672560
[TBL] [Abstract][Full Text] [Related]
8. A radical approach to achieve complete cytoreductive surgery improve survival of patients with advanced ovarian cancer.
Liberale G; Pop CF; Polastro L; Kerger J; Moreau M; Chintinne M; Larsimont D; Nogaret JM; Veys I
J Visc Surg; 2020 Apr; 157(2):79-86. PubMed ID: 31837942
[TBL] [Abstract][Full Text] [Related]
9. Cytoreduction (Peritonectomy Procedures) Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Advanced Ovarian Cancer: Retrospective Italian Multicenter Observational Study of 511 Cases.
Di Giorgio A; De Iaco P; De Simone M; Garofalo A; Scambia G; Pinna AD; Verdecchia GM; Ansaloni L; Macrì A; Cappellini P; Ceriani V; Giorda G; Biacchi D; Vaira M; Valle M; Sammartino P
Ann Surg Oncol; 2017 Apr; 24(4):914-922. PubMed ID: 27896512
[TBL] [Abstract][Full Text] [Related]
10. Morbidity and reversal rate of ileostomy after bowel resection during Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer.
Tozzi R; Casarin J; Garruto-Campanile R; Majd HS; Morotti M
Gynecol Oncol; 2018 Jan; 148(1):74-78. PubMed ID: 29169615
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for permanent stoma after rectal cancer surgery with temporary ileostomy.
Kim MJ; Kim YS; Park SC; Sohn DK; Kim DY; Chang HJ; Oh JH
Surgery; 2016 Mar; 159(3):721-7. PubMed ID: 26490725
[TBL] [Abstract][Full Text] [Related]
12. Predictive and Prognostic Implication of Bowel Resections During Primary Cytoreductive Surgery in Advanced Epithelial Ovarian Cancer.
Bartl T; Schwameis R; Stift A; Bachleitner-Hofmann T; Reinthaller A; Grimm C; Polterauer S
Int J Gynecol Cancer; 2018 Nov; 28(9):1664-1671. PubMed ID: 30371563
[TBL] [Abstract][Full Text] [Related]
13. Diverting ileostomy during primary debulking surgery for ovarian cancer: Associated factors and postoperative outcomes.
Tseng JH; Suidan RS; Zivanovic O; Gardner GJ; Sonoda Y; Levine DA; Abu-Rustum NR; Tew WP; Chi DS; Long Roche K
Gynecol Oncol; 2016 Aug; 142(2):217-24. PubMed ID: 27261325
[TBL] [Abstract][Full Text] [Related]
14. Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival?
Fader AN; Bergstrom J; Jernigan A; Tanner EJ; Roche KL; Stone RL; Levinson KL; Ricci S; Wethingon S; Wang TL; Shih IM; Yang B; Zhang G; Armstrong DK; Gaillard S; Michener C; DeBernardo R; Rose PG
Gynecol Oncol; 2017 Oct; 147(1):85-91. PubMed ID: 28768570
[TBL] [Abstract][Full Text] [Related]
15. Artificial intelligence weights the importance of factors predicting complete cytoreduction at secondary cytoreductive surgery for recurrent ovarian cancer.
Bogani G; Rossetti D; Ditto A; Martinelli F; Chiappa V; Mosca L; Leone Roberti Maggiore U; Ferla S; Lorusso D; Raspagliesi F
J Gynecol Oncol; 2018 Sep; 29(5):e66. PubMed ID: 30022630
[TBL] [Abstract][Full Text] [Related]
16. A restrictive stoma policy after colorectal anastomosis in ovarian cancer based on ghost ileostomy use.
Lago V; Albert MM; Cruz MA; Guijarro Campillo RA; Padilla-Iserte P; Matute L; Gurrea M; Flor B; Domingo S
Eur J Surg Oncol; 2024 Jun; 50(6):108325. PubMed ID: 38636248
[TBL] [Abstract][Full Text] [Related]
17. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
[TBL] [Abstract][Full Text] [Related]
18. A collaborative surgical approach to upper and lower abdominal cytoreductive surgery in ovarian cancer.
Eng OS; Raoof M; Blakely AM; Yu X; Lee SJ; Han ES; Wakabayashi MT; Yuh B; Lee B; Dellinger TH
J Surg Oncol; 2018 Jul; 118(1):121-126. PubMed ID: 29878375
[TBL] [Abstract][Full Text] [Related]
19. Abdominopelvic cytoreduction rates and recurrence sites in stage IV ovarian cancer: is there a case for thoracic cytoreduction?
Perri T; Ben-Baruch G; Kalfon S; Beiner ME; Helpman L; Hogen LB; Shapira-Frommer R; Korach J
Gynecol Oncol; 2013 Oct; 131(1):27-31. PubMed ID: 23880152
[TBL] [Abstract][Full Text] [Related]
20. [Impact of neoadjuvant chemotherapy on the survival of patients with stage IIIc and IV epithelial ovarian cancer].
Yan X; An N; Jiang GQ; Gao M; Gao YN
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):298-301. PubMed ID: 18788637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]